{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:47:56Z","timestamp":1759481276280},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.rmr.2015.06.010","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T09:16:44Z","timestamp":1438420604000},"page":"759-767","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cohorte DEFI-ALPHA et projet hospitalier de recherche clinique POLYGEN DEFI-ALPHA. \u00c9tude des facteurs cliniques, biologiques et g\u00e9n\u00e9tiques associ\u00e9s \u00e0 l\u2019apparition et \u00e0 l\u2019\u00e9volution de complications h\u00e9patiques chez les enfants pr\u00e9sentant un d\u00e9ficit en alpha-1\u00a0antitrypsine"],"prefix":"10.1016","volume":"32","author":[{"given":"P.","family":"Joly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Restier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bouchecareilh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lacan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chapuis-Cellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Francina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lachaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2015.06.010_bib0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1164\/rccm.201108-1428CI","article-title":"A review of alpha-1\u00a0antitrypsin deficiency","volume":"185","author":"Stoller","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2015.06.010_bib0185","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/S0140-6736(05)66781-5","article-title":"Alpha-1\u00a0antitrypsin deficiency","volume":"365","author":"Stoller","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2015.06.010_bib0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-3-16","article-title":"Hereditary alpha-1-antitrypsin deficiency and its clinical consequences","volume":"3","author":"Fregonese","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rmr.2015.06.010_bib0195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-med-042409-151920","article-title":"Alpha-1-antitrypsin deficiency: importance of proteasomal and autophagic degradative pathways in disposal of liver disease-associated protein aggregates","volume":"62","author":"Perlmutter","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.rmr.2015.06.010_bib0200","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpeds.2013.03.077","article-title":"Disorders of protein misfolding: alpha-1-antitrypsin deficiency as prototype","volume":"163","author":"Silverman","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2015.06.010_bib0205","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM197606102942404","article-title":"Liver disease in alpha 1\u00a0anti-trypsin deficiency detected by screening of 200,000\u00a0infants","volume":"294","author":"Sveger","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2015.06.010_bib0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/MPG.0000000000000196","article-title":"Appropriateness of newborn screening for \u03b11-antitrypsin deficiency","volume":"58","author":"Teckman","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.rmr.2015.06.010_bib0215","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1651-2227.1988.tb10767.x","article-title":"The natural history of liver disease in alpha 1-antitrypsin deficient children","volume":"77","author":"Sveger","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.rmr.2015.06.010_bib0220","first-page":"666","article-title":"Wherefore art thou liver disease associated with alpha-1\u00a0antitrypsin deficiency","volume":"22","author":"Sharp","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.rmr.2015.06.010_bib0225","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0168-8278(00)80320-7","article-title":"Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension","volume":"33","author":"De Franchis","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.rmr.2015.06.010_bib0230","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/ajg.2009.66","article-title":"Esophageal capsule endoscopy vs EGD for the evaluation of portal hypertension: a French prospective multicenter comparative study","volume":"104","author":"Lapalus","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rmr.2015.06.010_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a005801","article-title":"Hepatic fibrosis and carcinogenesis in \u03b11-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders","volume":"3","author":"Perlmutter","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.rmr.2015.06.010_bib0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.20275","article-title":"Cryptic haplotypes of SERPINA1\u00a0confer susceptibility to chronic obstructive pulmonary disease","volume":"27","author":"Chappell","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.rmr.2015.06.010_bib0245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.21979","article-title":"A polymorphism of the alpha-1\u00a0antitrypsin gene represents a risk factor for liver disease","volume":"47","author":"Chappell","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.rmr.2015.06.010_bib0250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/15412555.2013.765839","article-title":"Liver disease in alpha-1\u00a0antitrypsin deficiency: current understanding and future therapy","volume":"10","author":"Teckman","year":"2013","journal-title":"COPD"},{"key":"10.1016\/j.rmr.2015.06.010_bib0255","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-230X-10-22","article-title":"Prevalence of genetic polymorphisms in the promoter region of the alpha-1\u00a0antitrypsin (SERPINA1) gene in chronic liver disease: a case control study","volume":"10","author":"Kok","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.rmr.2015.06.010_bib0260","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4292\/wjgpt.v1.i5.94","article-title":"Z \u03b11-antitrypsin deficiency and the endoplasmic reticulum stress response","volume":"1","author":"Greene","year":"2010","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.rmr.2015.06.010_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1003989","article-title":"MAN1B1\u00a0deficiency: an unexpected CDG (congenital disorders of glycosylation)-II","volume":"9","author":"Rymen","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.rmr.2015.06.010_bib0270","doi-asserted-by":"crossref","first-page":"11844","DOI":"10.1074\/jbc.M114.552091","article-title":"A Golgi-localized mannosidase (MAN1B1) plays a non-enzymatic gatekeeper role in protein biosynthetic quality control","volume":"289","author":"Iannoti","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rmr.2015.06.010_bib0275","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1074\/jbc.274.9.5861","article-title":"Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome","volume":"274","author":"Liu","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rmr.2015.06.010_bib0280","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hep.22974","article-title":"Single nucleotide polymorphism-mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha-1-antitrypsin deficiency","volume":"50","author":"Pan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.rmr.2015.06.010_bib0285","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/hep.23170","article-title":"Polymorphism in the endoplasmic reticulum mannosidase I (MAN1B1) gene is not associated with liver disease in individuals homozygous for the Z variant of the alpha-1\u00a0antitrypsin protease inhibitor (PiZZ individuals)","volume":"50","author":"Chappell","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.rmr.2015.06.010_bib0290","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jcf.2007.10.004","article-title":"A single centre experience of liver disease in adults with cystic fibrosis 1995\u20132006","volume":"7","author":"Nash","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2015.06.010_bib0295","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"302","author":"Bartlett","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2015.06.010_bib0300","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"135","author":"Yin","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmr.2015.06.010_bib0305","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1242\/dmm.014092","article-title":"Mysteries of \u03b11-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease","volume":"7","author":"Ghouse","year":"2014","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.rmr.2015.06.010_bib0310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1242\/dmm.013474","article-title":"Mechanisms of protein-folding diseases at a glance","volume":"7","author":"Valastyan","year":"2014","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.rmr.2015.06.010_bib0315","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1534\/genetics.112.143487","article-title":"The endosomal protein-sorting receptor sortilin has a role in trafficking \u03b11-antitrypsin","volume":"192","author":"Gelling","year":"2012","journal-title":"Genetics"},{"key":"10.1016\/j.rmr.2015.06.010_bib0320","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1242\/jcs.125393","article-title":"Sorting receptor SORLA \u2013 a trafficking path to avoid Alzheimer disease","volume":"126","author":"Willnow","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1016\/j.rmr.2015.06.010_bib0325","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1\u00a0is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.rmr.2015.06.010_bib0330","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/518720","article-title":"A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population","volume":"81","author":"Liu","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rmr.2015.06.010_bib0335","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1212\/01.wnl.0000280581.39755.89","article-title":"Association between genetic variants in SORL1\u00a0and autopsy-confirmed Alzheimer disease","volume":"70","author":"Lee","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.rmr.2015.06.010_bib0340","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/archneurol.2009.101","article-title":"Implication of sex and SORL1\u00a0variants in italian patients with Alzheimer disease","volume":"66","author":"Cellini","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.rmr.2015.06.010_bib0345","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.neurobiolaging.2007.10.013","article-title":"SORL1\u00a0haplotypes modulate risk of Alzheimer's disease in Chinese","volume":"30","author":"Tan","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.rmr.2015.06.010_bib0350","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.22308","article-title":"SORCS1\u00a0alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk","volume":"69","author":"Reitz","year":"2011","journal-title":"Ann Neurol"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S076184251500265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S076184251500265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T09:50:15Z","timestamp":1537437015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S076184251500265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S076184251500265X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2015.06.010","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cohorte DEFI-ALPHA et projet hospitalier de recherche clinique POLYGEN DEFI-ALPHA. \u00c9tude des facteurs cliniques, biologiques et g\u00e9n\u00e9tiques associ\u00e9s \u00e0 l\u2019apparition et \u00e0 l\u2019\u00e9volution de complications h\u00e9patiques chez les enfants pr\u00e9sentant un d\u00e9ficit en alpha-1\u00a0antitrypsine","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2015.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 SPLF. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}